The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Crucially, the levels of miR-128-3p forms can also differ depending on the genetic and molecular background, as they correlated with the glioblastoma subtypes, with the most reduced expression in the most aggressive mesenchymal one.96,113”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [113]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
A microRNA array reveals extensive regulation of microRNAs during brain development
KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040
Self-citationp53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Nature · doi:10.1038/nature07443 · Cited by 767
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · cited 3×
“Cell lysis, protein quantitation and western blotting were performed as previously described (Papagiannakopoulos et al., 2008; Xu et al., 2009).”
MethodSelf-citationModulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626 · cited 2×
“miRNAs are emerging as major regulators of gene networks, which are dysregulated in diseases, including cancer (Ciafrè et al., 2005; Lu et al., 2005; Conti et al., 2009; Huse et al., 2009; Hatley et al., 2010).”
Research works printed but not linked: 32
- Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, You MJ et al. (2002). Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1: 269–277. · DOI
- Boockvar JA, Kapitonov D, Kapoor G, Schouten J, Counelis GJ, Bogler O et al. (2003). Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Mol Cell Neurosci 24: 1116–1130. · DOI
- Cheng LC, Pastrana E, Tavazoie M, Doetsch F . (2009). miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12: 399–408. · DOI · Paper page
- Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351–1358. · DOI · Paper page
- Conaco C, Otto S, Han J-J, Mandel G . (2006). Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA 103: 2422–2427. · DOI · Paper page
- Conti A, Aguennouz MH, La Torre D, Tomasello C, Cardali S, Angileri F et al. (2009). miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors. J Neurooncol 93: 325–332. · DOI
- Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC . (2001). PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15: 1913–1925. · DOI
- Doetsch F, Petreanu L, Caille I, Garcia-Verdugo J-M, Alvarez-Buylla A . (2002). EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36: 1021–1034. · DOI
- Filipowicz W, Bhattacharyya SN, Sonenberg N . (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102–114. · DOI
- Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683–2710. · DOI · Paper page
- Gangaraju VK, Lin H . (2009). MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10: 116–125. · DOI
- Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125–9130. · DOI · Paper page
- Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH et al. (2009). The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23: 1327–1337. · DOI · Paper page
- Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S et al. (2006). PDGFR±-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51: 187–199. · DOI
- Krichevsky AM, Sonntag K-C, Isacson O, Kosik KS . (2006). Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24: 857–864. · DOI · Paper page
- Lewis BP, Shih Ih, Jones-Rhoades MW, Bartel DP, Burge CB . (2003). Prediction of mammalian microRNA targets. Cell 115: 787–798. · DOI · Paper page
- Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H et al. (2011). Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146: 209–221. · DOI
- Liu T, Papagiannakopoulos T, Puskar K, Qi S, Santiago F, Clay W et al. (2007). Detection of a microRNA signal in an in vivo expression set of mRNAs. PLoS One 2: e804. · DOI
- Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834–838. · DOI
- Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, Gage FH et al. (2009). Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15: 110–116. · DOI
- Mukasa A, Wykosky J, Ligon KL, Chin L, Cavenee WK, Furnari F . (2010). Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence. Proc Natl Acad Sci 107: 2616–2621. · DOI
- Neveu P, Kye MJ, Qi S, Buchholz DE, Clegg DO, Sahin M et al. (2010). MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell 7: 671–681. · DOI
- Piccirillo SGM, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al. (2006). Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761–765. · DOI
- Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC . (2004). Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64: 4783–4789. · DOI
- Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396–401. · DOI
- Stiles CD, Rowitch DH . (2008). Glioma stem cells: a midterm exam. Neuron 58: 832–846. · DOI
- Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR et al. (2010). Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328: 1031–1035. · DOI
- Visvanathan J, Lee S, Lee B, Lee JW, Lee S-K . (2007). The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev 21: 744–749. · DOI · Paper page
- Wuchty S, Arjona D, Li AG, Kotliarov Y, Walling J, Ahn S et al. (2011). Prediction of associations between microRNAs and gene expression in glioma biology. PLoS One 6: e14681. · DOI
- Xu N, Papagiannakopoulos T, Pan GJ, Thomson JA, Kosik KS . (2009). MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647–658. · DOI
- Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X et al. (2009). MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 87: 43–51. · DOI · Paper page
- Zhang Y, Zhang Y-f, Bryant J, Charles A, Boado RJ, Pardridge WM . (2004). Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10: 3667–3677. · DOI
Cited by
Sorted by citations
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
Saadatpour, L., Fadaee, E., Fadaei, S., Nassiri Mansour, R., Mohammadi, M., Mousavi, S. M., Goodarzi, M., Verdi, J., & Mirzaei, H. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.48 · Cited by 244
Adlakha, Y. K., & Saini, N. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-33 · Cited by 213
MiR-128-3p – a gray eminence of the human central nervous system
Kiel, K., Król, S. K., Bronisz, A., & Godlewski, J. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102141 · Cited by 15
Metadata
- Authors
- Papagiannakopoulos, T., Friedmann-Morvinski, D., Neveu, P., Dugas, J. C., Gill, R. M., Huillard, E., Liu, C., Zong, H., Rowitch, D. H., Barres, B. A., Verma, I. M., & Kosik, K. S.
- Venue
- Oncogene
- Published
- 2011-08-29
- Volume
- 31
- Issue
- 15
- Pages
- 1884-1895
- ISSN
- 0950-9232
- 1476-5594
- PMC
- PMC4160048
- Cited by
- 157
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
